|
TARS
|
Tarsus Pharmaceuticals, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
STOK
|
Stoke Therapeutics, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
SEER
|
Seer, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
RPTX
|
Repare Therapeutics Inc.
|
0.00%
|
US
|
NASDAQ
|
|
RIGL
|
Rigel Pharmaceuticals, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
PTGX
|
Protagonist Therapeutics, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
PNTG
|
The Pennant Group, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
PMVP
|
PMV Pharmaceuticals, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
PHAT
|
Phathom Pharmaceuticals, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
PAHC
|
Phibro Animal Health Corporation
|
0.00%
|
US
|
NASDAQ
|
|
ORGO
|
Organogenesis Holdings Inc.
|
0.00%
|
US
|
NASDAQ
|
|
NUVB
|
Nuvation Bio Inc.
|
0.00%
|
US
|
NYSE
|
|
MGTX
|
MeiraGTx Holdings plc
|
0.00%
|
US
|
NASDAQ
|
|
MDXG
|
MiMedx Group, Inc
|
0.00%
|
US
|
NASDAQ
|
|
LUNG
|
Pulmonx Corporation
|
0.00%
|
US
|
NASDAQ
|
|
JYNT
|
The Joint Corp.
|
0.00%
|
US
|
NASDAQ
|
|
JANX
|
Janux Therapeutics, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
IPSC
|
Century Therapeutics, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
IGMS
|
IGM Biosciences, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
HUMA
|
Humacyte, Inc.
|
0.00%
|
US
|
NASDAQ
|